614. Evaluating the Use of Dalbavancin for Off-Label Indications

BACKGROUND: Dalbavancin (dalba) is a long-acting antibiotic (ABX) approved for skin and soft tissue infections. Post-marketing data suggests dalba is being used for off-label indications that require long term IV ABX; however, data assessing this off-label usage is limited. The purpose of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, Katherine, Williamson, John, Stone, Tyler, Johnson, James, Gruss, Zachary, Luther, Vera, Russ-Friedman, Courtney, Ohl, Chris, Beardsley, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643763/
http://dx.doi.org/10.1093/ofid/ofab466.812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643763/
http://dx.doi.org/10.1093/ofid/ofab466.812

Ejemplares similares